PharmaShots Weekly Snapshots (December 12 - 16, 2022)
Published: Dec 16, 2022 | Tags: Kintara Therapeutics, VAL-083, Diffuse Intrinsic Pontine Glioma, US, FDA, Orphan Drug Designation, Regulatory
Published: Dec 16, 2022 | Tags: Pfizer, Anumana, Cardiac Amyloidosis, AI Algorithm, low ejection fraction, pulmonary hypertension, hyperkalemia, Pharma
BioCryst Discontinues Development of BCX9930 for Paroxysmal Nocturnal Hemoglobinuria
Published: Dec 16, 2022 | Tags: BioCryst, BCX9930, BCX10013, Paroxysmal Nocturnal Hemoglobinuria, Renal Diseases, Pharma
Guardant Health Reports (ECLIPSE) Study Results of Blood Test for the Detection of Colorectal Cancer
Published: Dec 16, 2022 | Tags: Guardant Health, Blood Test, Colorectal Cancer, Clinical Trial, MedTech, ECLIPSE Study
Published: Dec 16, 2022 | Tags: Sosei Heptares, Eli Lilly, Small Molecules, Diabetes and Metabolic Diseases, Drug Discovery Collaboration, StaR technology, SBDD platform, Biotech
Medtronic Reports the First Patient Enrollment of Hugo Robotic-Assisted Surgery System
Published: Dec 16, 2022 | Tags: Medtronic, Hugo Robotic-Assisted Surgery System, MedTech, Expand URO US clinical trial
Published: Dec 15, 2022 | Tags: Eisai, Neurodegenerative Diseases, dominantly inherited Alzheimer's disease, P-II/III, Tau NexGen Study, Pharma
Published: Dec 15, 2022 | Tags: Sanofi, Regeneron, Dupixent, dupilumab, Prurigo Nodularis, Regulatory, EC, Approval
Published: Dec 15, 2022 | Tags: Innovent, LG Chem, Tigulixostat, hyperuricemia, Gout Disease, Pharma
Published: Dec 15, 2022 | Tags: Boehringer Ingelheim, Ofev, nintedanib, Idiopathic Pulmonary Fibrosis, Regulatory, NICE
Published: Dec 15, 2022 | Tags: Ono, PrecisionLife, central nervous system disorders, Novel Therapeutic Targets, combinatorial analytics platform, Biotech
Published: Dec 15, 2022 | Tags: Krystal Biotech, Beremagene Geperpavec, Dystrophic Epidermolysis Bullosa, Clinical Trial, P-III, GEM-3 Trial
Published: Dec 14, 2022 | Tags: BeiGene, Brukinsa, zanubrutinib, Chronic Lymphocytic Leukemia, Clinical Trial, P-III, ALPINE Trial, ASH, 2022
AEON Biopharma to Go Public via Priveterra SPAC Merger for ~$475.5M
Published: Dec 14, 2022 | Tags: AEON Biopharma, Priveterra, ABP-450, cervical dystonia, episodic migraine, SPAC Merger, M&A
Published: Dec 14, 2022 | Tags: Moderna, Merck, mRNA-4157/V940, Keytruda, Stage III/IV Melanoma, Clinical Trial, P-IIb, KEYNOTE-942
GSK Collaborated with Wave Life Sciences to Advance Oligonucleotide Therapies
Published: Dec 14, 2022 | Tags: GSK, Wave Lifesciences, Oligonucleotide Therapies, WVE-006, Bepirovirsen, GSK4532990, hepatitis B infection, Biotech
Published: Dec 14, 2022 | Tags: Novartis, Iptacopan, Paroxysmal Nocturnal Hemoglobinuria, Clinical Trial, P-III, APPLY-PNH Trial, ASH, 2022
Takeda Entered into an Agreement to Acquire NDI-034858 from Nimbus Therapeutics for ~$6B
Published: Dec 14, 2022 | Tags: Takeda, NDI-034858, Nimbus Therapeutics, plaque psoriasis, psoriatic arthritis, ~$6B, M&A
The EU Council Provides Updates on New Cancer Screening Recommendations
Published: Dec 13, 2022 | Tags: EU Council, New Cancer Screening Recommendations, EU4Health Programme, Horizon Europe, 2023 EU4Health work program, Pharma
Published: Dec 13, 2022 | Tags: Mirum Pharmaceuticals, LIVMARLI, maralixibat, Cholestatic Pruritus, Alagille Syndrome, EC, Regulatory
Published: Dec 13, 2022 | Tags: Agilent Technologies, Agilent Resolution ctDx FIRST Test, Advanced Non-Small Cell Lung Cancer, Regulatory, US, FDA, Approval
Published: Dec 13, 2022 | Tags: Mirati Therapeutics, Krazati, adagrasib, Non-Small Cell Lung Cancer, Regulatory, US, FDA, Approval
Published: Dec 13, 2022 | Tags: Arcutis, Roflumilast, Atopic Dermatitis, Clinical Trial, P-III, INTEGUMENT-2
Published: Dec 13, 2022 | Tags: Janssen, Darzalex, Multiple Myeloma, Clinical Trial, P-III, MAIA Study, ASH, 2022
Published: Dec 12, 2022 | Tags: Janssen, Talquetamab, Multiple Myeloma, BLA, US, FDA, Regulatory
Published: Dec 12, 2022 | Tags: Arcellx, Kite, CART-ddBCMA, Multiple Myeloma, ARC-SparX programs, Pharma
Published: Dec 12, 2022 | Tags: Janssen, Imbruvica, ibrutinib, Venetoclax, Chronic Lymphocytic Leukemia, Clinical Trial, P-III, GLOW Study, ASH, 2022
Published: Dec 12, 2022 | Tags: GSK, Momelotinib, Myelofibrosis, Clinical Trial, P-III, MOMENTUM Trial, ASH, 2022
Published: Dec 12, 2022 | Tags: Pfizer, Elranatamab, Multiple Myeloma, Clinical Trial, P-II, MagnetisMM-3 Trial, ASH, 2022
Novartis Entered into an Exclusive Worldwide License Agreement with Erasca for Naporafenib
Published: Dec 12, 2022 | Tags: Novartis, Erasca, Naporafenib, NRAS mutant melanoma, RAS/MAPK pathway-driven tumors, Pharma
Related Post: PharmaShots Weekly Snapshots (December 05–09, 2022)
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.